← Leaderboards
Joseph Jacob Stevens
Cincinnati Childrens Hosp Med Ctr
$188,376
Attributed
$188,376
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54.1K · FY2022–25$100K$75K$50K$25K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$188,376 · 1
By mechanism
F30$188,376 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Lilliam Ambroggio$1,335,735
- Nathan G. Salomonis$7,654,822
- Jeffery D Molkentin$48,923,505
- H Leighton Grimes$23,205,568
- Ian Paul Lewkowich$6,739,276
Others in their field
Other Rising Stars on “Adoptive Transfer”
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$3,559,750
- Torben Schiffner · Vanderbilt University$3,383,634
- John-Paul F Navarro · University Of Illinois At Urbana-Champaign$3,377,803
- Winona Snapp-Childs · University Of Illinois At Urbana-Champaign$3,377,803
Research focus
Adoptive TransferAffectAdultAntibioticsAntibiotic TherapyAutomobile DrivingAge GroupBehavior ControlCareerCd8b1 GeneCd8-Positive T-LymphocytesCell BehaviorCell PhysiologyCellsCellular AssayCellular Indexing Of Transcriptomes And Epitopes By SequencingCessation Of LifeChildhoodChromatinClinicCommensal MicrobesComplexCross ImmunityCytokine
Grant awards (5)
CD8+ tissue-resident immunity to primary and heterotypic Influenza A controlled by commensal microbiota$54,074
F30 · FY2025 · HL · contact PI
CD8+ tissue-resident immunity to primary and heterotypic Influenza A controlled by commensal microbiota$53,974
F30 · FY2024 · HL · contact PI
CD8+ tissue-resident immunity to primary and heterotypic Influenza A controlled by commensal microbiota$27,117
F30 · FY2023 · HL · contact PI
CD8+ tissue-resident immunity to primary and heterotypic Influenza A controlled by commensal microbiota$13,518
F30 · FY2023 · HL · contact PI
CD8+ tissue-resident immunity to primary and heterotypic Influenza A controlled by commensal microbiota$39,693
F30 · FY2022 · HL · contact PI